Drug transport by breast cancer resistance protein

Maren Poguntke1, Eszter Hazai, Martin F Fromm

  • 1University of Erlangen-Nuremberg, Institute of Experimental and Clinical Pharmacology and Toxicology, Fahrstr. 17, 91054 Erlangen, Germany.

Abstract

Insights

The ATP-binding cassette transporter ABCG2 impacts drug pharmacokinetics, safety, and efficacy. Understanding ABCG2 drug interactions is crucial for effective cancer drug development and personalized medicine.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Drug Development

Background:

  • The ATP-binding cassette transporter ABCG2 is a key factor in cancer multi-drug resistance.
  • ABCG2 significantly influences drug pharmacokinetics, safety, and efficacy.
  • Recent studies highlight ABCG2's role beyond resistance, impacting drug profiles.

Purpose of the Study:

  • To review clinical evidence on ABCG2's role in pharmacokinetics and pharmacodynamics.
  • To address preclinical drug evaluation questions regarding ABCG2.
  • To provide an update on ABCG2's importance in drug disposition and development.

Main Methods:

  • Review of clinical evidence on ABCG2's role.
  • Discussion of ABCG2 structure and drug-transporter interactions.
  • Exploration of ABCG2 polyspecificity mechanisms.
  • Evaluation of in vitro and in silico methods for studying ABCG2 interactions.

Main Results:

  • ABCG2 is critical in drug disposition, particularly in drug development.
  • Current knowledge emphasizes ABCG2's influence on drug safety and efficacy.
  • The review provides an update on ABCG2's role in drug development.

Conclusions:

  • Drug-ABCG2 interactions are advancing into clinical practice.
  • Structural understanding of ABCG2 binding and transport remains incomplete.
  • Novel concepts like electrostatic funneling may explain ABCG2 multispecificity and aid in silico predictions.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...